CRISPR Therapeutics $2.4 Billion Cash: Why the Stock Slump Persists
CRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Explore actionable methods to keep spending in check and align it with your budget. This intro provides simple, repeatable practices for effective management.
17,183 articlesCRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Chrysler is recalling over a million Jeep Wrangler and Gladiator models due to a fire risk when the vehicles are park...
A leading hedge fund investor says the current AI rally is fundamentally different from the late-1990s bubble, citing...
Artificial intelligence is delivering measurable efficiency in health care, but the race now focuses on who benefits—...
Honda is recalling nearly 900,000 vehicles after rear-suspension corrosion could cause loss of control. The recall co...
Tech stocks retreat sparked a broader market pause, but analysts insist the stock market isn’t crashing — it’s a rota...
As self-driving tech moves from labs to city streets, control of the platform becomes the real battleground. This art...
Osasuna is under fire after reports it used a Kalshi contract to hedge the financial hit of relegation. The club deni...
As retirees navigate 2026 finances, a persistent tax cliff on Social Security benefits catches many singles off guard...
CME's 24/7 bitcoin futures trading is forcing a new look at risk. Early data show heavy weekend activity and shifting...
Turn a single property into a multi-tenant assisted living setup. Discover practical steps to make more money with th...
New 2026 guidance shows high earners with million+ 401(k)s can still build tax-free Roth assets through after-tax con...